CAS No. |
56391-56-1 |
中文名称 |
(2R,3R,4R,5R)-2-[[(1S,2S,3R,4S,6R)-4-氨基-3-[[(2S,3R)-3-氨基-6-(氨甲基)-3,4-二氢-2H-吡喃-2-基]氧基]-6-(乙氨基)-2-羟基环己基]氧基]-5-甲基-4-(甲氨基)四氢-2H-吡喃-3,5-二醇 |
英文名称 |
(2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4-Amino-3-(((2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-6-(ethylamino)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol |
别名 |
1-N-Ethylsisomicin | NSC-759586 | Vectacin | Netilmicine | UNII-4O5J85GJJB | Netilmicinum | Nettacin | Netilyn | 1-N-Aethylsisomicin | Netilmicin [INN:BAN] | NTL | netilmicin | Netilmicin (INN) | NETILMICIN SULFATE | Netira | Netilmicina | Sch 20569 |
标准英文名 |
(2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4-amino-3-(((2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-6-(ethylamino)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol |
MDL No. |
MFCD00869454 |
分子式 |
C21H41N5O7 |
分子量 |
475.59
|
精确分子量 |
475.30
|
SMILES |
O([C@@H]1[C@@H](O)[C@H](O[C@@]([H])2[C@H](N)CC=C(CN)O2)[C@@H](N)C[C@H]1NCC)[C@]([H])1OC[C@@](O)(C)[C@H](NC)[C@H]1O |
标准SMILES |
CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)NCC)OC[C@]1(C)O |
用途 |
Netilmicin is used for the treatment of respiratory tract infections, skin and soft tissue infections, urinary tract infections, wound infections, bone and joint infections, postpartum infections, gastrointestinal and biliary tract infections, and sepsis. It is particularly effective against gentamicin-resistant enteric bacteria and Pseudomonas aeruginosa, with a lower risk of ototoxicity and nephrotoxicity compared to other clinically used aminoglycoside antibiotics. |
InChIKey |
CIDUJQMULVCIBT-MQDUPKMGSA-N |